E Meditek Insurance Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 30-12-2024
- Paid Up Capital ₹ 4.01 Cr
as on 30-12-2024
- Company Age 24 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.85 Cr
as on 30-12-2024
- Satisfied Charges ₹ 37.96 Cr
as on 30-12-2024
About E Meditek Insurance
The Corporate was formerly known as Suprema Insurance Services Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.01 Cr.
The company currently has active open charges totaling ₹21.85 Cr. The company has closed loans amounting to ₹37.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gopal Verma, Nisha Verma, Ahmed Tameem, and One other member serve as directors at the Company.
- CIN/LLPIN
U72200DL2000PLC106100
- Company No.
106100
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at E Meditek Insurance?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Verma  | Managing Director | 27-Feb-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nisha Verma | Director | 05-Jun-2000 | Current |
| Ahmed Tameem | Director | 09-Aug-2013 | Current |
| Gautam Kumar | Director | 23-Aug-2023 | Current |
Financial Performance of E Meditek Insurance.
E Meditek Insurance Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of E Meditek Insurance?
In 2023, E Meditek Insurance had a promoter holding of 95.57% and a public holding of 4.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 05 Oct 2015 | ₹2.99 Cr | Open |
Icici Bank Limited Creation Date: 05 Oct 2015 | ₹2.99 Cr | Open |
Others Creation Date: 17 Apr 2004 | ₹15.87 Cr | Open |
How Many Employees Work at E Meditek Insurance?
Unlock and access historical data on people associated with E Meditek Insurance, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of E Meditek Insurance, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped E Meditek Insurance's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
